CAS 4776-06-1: 3,5-Dibromo-2-hydroxy-N-(3-(trifluoromethyl)phenyl)benzamide

Fluorosalan is a topical antiseptic, which is a fluorinated salicylamide derivative with bacteriostatic properties. This product is synthesized through the halogenation of salicylamide, a compound known for its antimicrobial effects. The incorporation of fluorine enhances the chemical stability and increases its effectiveness against a broad spectrum of pathogenic microorganisms. The mode of action of Fluorosalan involves the disruption of microbial cell membranes and inhibition of essential enzyme systems within the pathogen, thus preventing their replication and survival. Its efficacy is attributed to its ability to interfere with microbial metabolism and cellular integrity effectively. Fluorosalan is predominantly employed in clinical settings for the treatment of superficial skin infections and as a preventive measure in surgical procedures to reduce infection rates. The application is typically through topical formulations, enabling direct delivery to the site of infection and minimizing systemic side effects. Due to its potent antibacterial properties and low incidence of resistance, Fluorosalan remains a critical component in infection control protocols.

Applications Fluorosalan is used in pharmacological activity and biological study for identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action in cancer therapy. Anti-bacterial agent used in handwash solutions. References Miller, S.C., et al.: Biochem. Pharmacol., 79, 1272-1280 (2010);